Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Adami, Eleonora Dr. (1) Bader, Michael Prof. Dr. (1) Begay-Müller, Valerie Dr. (1) Birchmeier, Walter Prof. Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Gerlach, Kerstin (1) Gotthardt, Michael Prof. Dr. (1) Hinz, Michael Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Landthaler, Markus Prof. Dr. (1) Leutz, Achim Prof. Dr. (1) Lewin, Gary Prof. Dr. (1) Lusatis, Simone (1) Maatz, Henrike Dr. (1) Mathas, Stephan Dr. (11) Müller, Thomas Dr. (1) Rajewsky, Klaus Prof. Dr. (2) Rajewsky, Nikolaus Prof. Dr. (3) Rehm, Armin Dr. (1) Rother, Franziska Dr. (1) Selbach, Matthias Prof. Dr. (17) Singh, Manvendra Dr. (1) Sommer, Christian (1) Wollert-Wulf, Brigitte (2) Zauber, Henrik Dr. (1) (-) Herzog, Margareta (1) (-) Janz, Martin Dr. (6) (-) Kirchner, Marieluise Dr. (3) (-) Radke, Michael Dr. (1) (-) Scheidereit, Claus Prof. Dr. (4) (-) Biologie maligner Lymphome (9) Genetik und Genomik von Herz- Kreislauferkrankungen (2) Immunregulation und Krebs (1) Mathematische Modellierung zellulärer Prozesse (1) (-) Proteom Dynamik (3) RNA Biologie und Posttranscriptionale Regulation (2) Systembiologie von Gen-regulatorischen Elementen (4) Translationale Kardiologie und Funktionelle Genomforschung (2) Zellzustände und ihre Funktionsweisen (1) 1999 (2) 2000 (1) 2001 (1) (-) 2002 (4) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (4) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (5) 2012 (4) 2013 (2) (-) 2014 (4) 2015 (3) 2016 (2) 2017 (5) 2018 (3) 2019 (1) 2020 (4) 2021 (3) 2022 (5) 2023 (6) 2024 (1) 12 Ergebnisse: Active Filter: Herzog, MargaretaJanz, Martin Dr.Kirchner, Marieluise Dr.Radke, Michael Dr.Scheidereit, Claus Prof. Dr.Biologie maligner LymphomeProteom Dynamik200220062014 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 01. Januar 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer 02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit 15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken 13. November 2014 / eLife Drep-2 is a novel synaptic protein important for learning and memory T.F.M. Andlauer S. Scholz-Kornehl R. Tian M. Kirchner H.A. Babikir H. Depner B. Loll C. Quentin V.K. Gupta M.G. Holt S. Dipt M. Cressy M.C. Wahl A. Fiala M. Selbach M. Schwärzel S.J. Sigrist 21. Oktober 2014 / Proc Natl Acad Sci U S A Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma S. Kreher M.A. Bouhlel P. Cauchy B. Lamprecht S. Li M. Grau F. Hummel K. Köchert I. Anagnostopoulos K. Jöhrens M. Hummel J. Hiscott S.S. Wenzel P. Lenz M. Schneider R. Küppers C. Scheidereit M. Giefing R. Siebert K. Rajewsky G. Lenz P.N. Cockerill M. Janz B. Dörken C. Bonifer S. Mathas 01. August 2014 / J Clin Invest RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing H. Maatz M. Jens M. Liss S. Schafer M. Heinig M. Kirchner E. Adami C. Rintisch V. Dauksaite M.H. Radke M. Selbach P.J.R. Barton S.A. Cook N. Rajewsky M. Gotthardt M. Landthaler N. Hubner Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
01. Januar 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer
02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit
15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken
13. November 2014 / eLife Drep-2 is a novel synaptic protein important for learning and memory T.F.M. Andlauer S. Scholz-Kornehl R. Tian M. Kirchner H.A. Babikir H. Depner B. Loll C. Quentin V.K. Gupta M.G. Holt S. Dipt M. Cressy M.C. Wahl A. Fiala M. Selbach M. Schwärzel S.J. Sigrist
21. Oktober 2014 / Proc Natl Acad Sci U S A Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma S. Kreher M.A. Bouhlel P. Cauchy B. Lamprecht S. Li M. Grau F. Hummel K. Köchert I. Anagnostopoulos K. Jöhrens M. Hummel J. Hiscott S.S. Wenzel P. Lenz M. Schneider R. Küppers C. Scheidereit M. Giefing R. Siebert K. Rajewsky G. Lenz P.N. Cockerill M. Janz B. Dörken C. Bonifer S. Mathas
01. August 2014 / J Clin Invest RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing H. Maatz M. Jens M. Liss S. Schafer M. Heinig M. Kirchner E. Adami C. Rintisch V. Dauksaite M.H. Radke M. Selbach P.J.R. Barton S.A. Cook N. Rajewsky M. Gotthardt M. Landthaler N. Hubner